How AbbVie’s Humira Still Reigns, Despite New Competition
Wall Street Journal
Revenue for blockbuster arthritis drug declined in the second quarter, largely due to discounts for middlemen.
https://www.wsj.com/articles/how-abbvies-humira-still-reigns-despite-new-competition-d4aa13a9